Our results suggest that aberrant expression of NT3, pro-NT3 and P75NTR is associated with photoreceptor degeneration and that treatment with mature NT3 together with inhibition of pro-NT3/P75NTR signaling may represent a novel pharmacological strategy for protecting photoreceptors in retinal disease. This evidence concerns the gene NGFR and Abnormal retinal morphology.